Calculate your BMI and check eligibility.

For most adults, a body mass index (BMI) between 18.5 and 24.9 is considered the healthy range, 25.0–29.9 is classified as overweight, and 30.0 or higher is classified as obesity. BMI is a screening tool, not a diagnosis — it does not account for muscle mass, bone density, or where body fat is distributed, so your provider considers it alongside other factors.

In line with FDA labeling for GLP-1 medications, treatment is generally considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. A licensed REMEVi provider reviews your full health history to determine whether treatment is appropriate for you.

No. BMI does not distinguish between muscle and fat, so very muscular people can have a high BMI without excess body fat, and older adults can have a normal BMI while carrying excess fat. It also does not capture where fat is stored. Use it as a starting point and let a licensed provider interpret it in the context of your overall health.

BMI moves down as body weight decreases relative to height. Sustainable changes — a modest calorie deficit, more protein, regular movement, and good sleep — are the foundation. For people who qualify, medically supervised GLP-1 treatment can support appetite regulation alongside those changes. Any plan should be guided by a licensed provider.